TAYLOR FONTAINE: Open Payments
NPI 1033593025 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 15 payments from 10 companies in 2025. Trend: 2023 $418 · 2024 $347 · 2025 $327
Food & beverage: $266Education: $61
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $61 |
| Medtronic, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| LEO Pharma Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $14 |
Products named: BREZTRI, INTERSTIM, DUPIXENT, EBGLYSS, WAKIX, TEZSPIRE, Kerendia, CAPLYTA.
Industry payments across ND — which companies pay providers there.
